#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3384153	F	Inhibition of LPS-induced NO production in C57BL/6 mouse macrophages preincubated with compound for 1 hr before LPS challenge measured after 24 hrs by Griess method	Mus musculus	13		cell-based format	Scientific Literature
2.	ALA3384154	A	Cytotoxicity against C57BL/6 mouse macrophages after 24 hrs by MTT assay	Mus musculus	13		cell-based format	Scientific Literature
3.	ALA3384155	U	Selectivity index, ratio of IC50 for C57BL/6 mouse macrophages to IC50 for LPS-induced NO production in C57BL/6 mouse macrophages	Mus musculus	11		cell-based format	Scientific Literature
4.	ALA3384156	F	Inhibition of intrinsic NO production in C57BL/6 mouse macrophages at 10 uM measured after 24 hrs by Griess method	Mus musculus	6		cell-based format	Scientific Literature
5.	ALA3384158	F	Antiinflammatory activity in Kunming mouse assessed as inhibition of croton oil-induced ear edema at 5 umol/kg, po administered before challenge relative to vehicle-treated control	Mus musculus	3		organism-based format	Scientific Literature
6.	ALA3384159	F	Antiinflammatory activity in Kunming mouse assessed as inhibition of croton oil-induced ear edema at 10 umol/kg, po administered before challenge relative to vehicle-treated control	Mus musculus	3		organism-based format	Scientific Literature
7.	ALA3384160	F	Antiinflammatory activity in Kunming mouse assessed as inhibition of croton oil-induced ear edema at 20 umol/kg, po administered before challenge relative to vehicle-treated control	Mus musculus	3		organism-based format	Scientific Literature
8.	ALA3384164	F	Antiinflammatory activity in specific pathogen-free COPD-like lung inflammation BALB/c mouse model assessed as inhibition of neutrophils at 2 umol/kg/day, po for 35 days measured 24 hrs post last dose relative to vehicle-treated control	Mus musculus	1		organism-based format	Scientific Literature
9.	ALA3384744	F	Antiinflammatory activity in specific pathogen-free COPD-like lung inflammation BALB/c mouse model assessed as inhibition of white blood cells at 2 umol/kg/day, po for 35 days measured 24 hrs post last dose relative to vehicle-treated control	Mus musculus	2		organism-based format	Scientific Literature
10.	ALA3384745	F	Antiinflammatory activity in specific pathogen-free COPD-like lung inflammation BALB/c mouse model assessed as inhibition of eosinophils at 2 umol/kg/day, po for 35 days measured 24 hrs post last dose relative to vehicle-treated control	Mus musculus	2		organism-based format	Scientific Literature
11.	ALA3384746	F	Antiinflammatory activity in specific pathogen-free COPD-like lung inflammation BALB/c mouse model assessed as inhibition of TNFalpha level at 2 umol/kg/day, po for 35 days measured 24 hrs post last dose relative to vehicle-treated control	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA3384747	F	Antiinflammatory activity in specific pathogen-free COPD-like lung inflammation BALB/c mouse model assessed as inhibition of IL-1beta level at 2 umol/kg/day, po for 35 days measured 24 hrs post last dose relative to vehicle-treated control	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA3384748	F	Antiinflammatory activity in specific pathogen-free COPD-like lung inflammation BALB/c mouse model assessed as inhibition of IL-6 level at 2 umol/kg/day, po for 35 days measured 24 hrs post last dose relative to vehicle-treated control	Mus musculus	2		organism-based format	Scientific Literature
14.	ALA3384749	T	Toxicity in Kunming mouse administered orally as single dose measured over 14 days	Mus musculus	3		organism-based format	Scientific Literature